Skip to content

Clinical trials

Terminated Phase 3 Hepatitis C trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Phase: Phase 3 Status: Terminated Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20061
20082
20091
20101
20112
20122
20132
20152
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Debiopharm International SA2
French National Agency for Research on AIDS and Viral Hepatitis2
Anna Cruceta1
Dr. Nadia AbdelAaty AbdelKader1
Foundation for Liver Research1
Gilead Sciences1
GlaxoSmithKline1
Janssen Research & Development, LLC1
M.D. Anderson Cancer Center1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C16
Hepatitis C, Chronic7
HIV Infections2
Acquired Immunodeficiency Syndrome1
Bronchiolitis Obliterans Syndrome1
Carcinoma, Hepatocellular1
Coinfection1
Fatty Liver1
Hepatitis B1
Infections1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.